Evidence map›Paper›PMID 28651021›Full record

ArticlePloS one2017

Natural immune response to Plasmodium vivax alpha-helical coiled coil protein motifs and its association with the risk of P. vivax malaria.

Nora Céspedes, Connie S N Li Wai Suen, Cristian Koepfli, Camila T França, Ingrid Felger, Issa Nebie, Myriam Arévalo-Herrera, Ivo Mueller, Giampietro Corradin, Sócrates Herrera

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Frontiers in immunology · 2020
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 6 countries.

Nora CéspedesMalaria Vaccine and Drug Development Center (MVDC), Cali, Colombia.
Connie S N Li Wai SuenPopulation Health & Immunity Division, Walter and Eliza Hall Institute of Medical Research, Parkville, Australia.
Cristian KoepfliPopulation Health & Immunity Division, Walter and Eliza Hall Institute of Medical Research, Parkville, Australia.
Camila T FrançaPopulation Health & Immunity Division, Walter and Eliza Hall Institute of Medical Research, Parkville, Australia.
Ingrid FelgerSwiss Tropical and Public Health Institute, Basel, Switzerland.
Issa NebieCentre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso.
Myriam Arévalo-HerreraMalaria Vaccine and Drug Development Center (MVDC), Cali, Colombia.
Ivo MuellerPopulation Health & Immunity Division, Walter and Eliza Hall Institute of Medical Research, Parkville, Australia.
Giampietro CorradinBiochemistry Department, University of Lausanne, Epalinges, Switzerland.
Sócrates HerreraMalaria Vaccine and Drug Development Center (MVDC), Cali, Colombia.ORCID http://orcid.org/0000-0002-4688-0598
Caucaseco Scientific Research Center · COThe University of Melbourne · AUCentre National de Recherche et de Formation sur le Paludisme · BFInstitut Pasteur · FRSwiss Tropical and Public Health Institute · CHUniversity of Lausanne · CH

Funding

Vector Biology Research and Integrated Vector Management For Malaria ControlU19AI089702 · NIAID · CAUCASECO SCIENTIFIC RESEARCH CENTER · PI HERRERA VALENCIA, SOCRATES · 2010 to 2016
$11.5M
NIAID NIH HHS U19 AI089702
6 · The paper itself

Abstract

Protein α-helical coiled coil structures are known to induce antibodies able to block critical functions in different pathogens. In a previous study, a total of 50 proteins of Plasmodium vivax erythrocytic asexual stages containing α-helical coiled coil structural motifs were identified in silico, and the corresponding peptides were chemically synthesized. A total of 43 peptides were recognized by naturally acquired antibodies in plasma samples from both Papua New Guinea (PNG) and Colombian adult donors. In this study, the association between IgG antibodies to these peptides and clinical immunity was further explored by measuring total IgG antibody levels to 24 peptides in baseline samples from a longitudinal study of children aged 1-3 years (n = 164) followed for 16 months. Samples were reactive to all peptides tested. Eight peptides were recognized by >50% of individuals, whereas only one peptide had < 20% reactivity. Children infected at baseline were seropositive to 23/24 peptides. No significant association was observed between antibody titers and age or molecular force of infection, suggesting that antibody levels had already reached an equilibrium. There was a strong association between antibody levels to all peptides and protection against P. vivax clinical episodes during the 16 months follow-up. These results suggest that the selected coiled coil antigens might be good markers of both exposure and acquired immunity to P. vivax malaria, and further preclinical investigation should be performed to determine their potential as P. vivax vaccine antigens.

Indexed as

Amino Acid SequenceAnimalsAntibodies, ProtozoanAntigens, ProtozoanChild, PreschoolHumansImmunity, InnateImmunoglobulin GInfantLongitudinal StudiesMalaria VaccinesMalaria, VivaxPapua New GuineaPeptidesPlasmodium vivaxProtein Conformation, alpha-HelicalAntibodies, ProtozoanAntigens, ProtozoanImmunoglobulin GMalaria VaccinesPeptidesProtozoan Proteins

Identifiers

PMID28651021
PMCPMC5484505
OpenAlexW2716078583

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.